4:41 PM
 | 
Jul 07, 2014
 |  BC Extra  |  Financial News

CareDx, Pfenex set IPO terms

Molecular diagnostics company CareDx Inc. (Brisbane, Calif.) and biosimilar play Pfenex Inc. (San Diego, Calif.) both set IPO terms on Monday. CareDx (formerly XDX Inc.) plans to sell 3.1 million shares at $15-$17 in an IPO on NASDAQ underwritten by Piper Jaffray; Leerink; Raymond James; and Mizuho Securities....

Read the full 228 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >